Related Experiment Video
Updated: Jul 25, 2026
13:35
A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites
Published on: March 1, 2018
Further studies on age-related unusual catecholamine structures in brain
Neurobiology of Aging
|January 1, 1983
Summary
Large, intensely fluorescent (LIF) spots in the brain increase with age in mice and rats. Antioxidants did not affect LIF spot numbers, suggesting a non-free radical mechanism for their age-related formation.
Area of Science:
- Neuroscience
- Aging Research
- Biochemistry
Background:
- Large, intensely fluorescent (LIF) spots containing catecholamines are observed in rodent brains.
- The biological significance and formation mechanism of these LIF spots, particularly in relation to aging, remain unclear.
Purpose of the Study:
- To investigate the occurrence and characteristics of LIF spots in the brains of mice and rats.
- To determine the influence of age, sex, strain, and antioxidants on LIF spot formation.
Main Methods:
- Fluorescence microscopy was employed to visualize and quantify LIF spots in the brains of C57BL/6J mice and rats of various strains.
- Mice were fed a long-term diet supplemented with antioxidants (ascorbic acid, alpha-tocopherol, beta-mercaptoethylamine).
Main Results:
- LIF spot numbers increased progressively with age in C57BL/6J mice.
- No significant sex-based differences in LIF spot numbers were observed.
- Increased LIF spots were found in older mice and rats across different strains, indicating non-specific formation.
- Antioxidant supplementation did not significantly alter the number of LIF spots in mice.
Conclusions:
- Age-related formation of LIF spots in rodent brains is not strain or species-specific.
- The formation mechanism of age-related LIF spots likely does not involve endogenous free radical damage, as antioxidant treatment had no significant effect.
Related Concept Videos
01:27Adrenergic Neurons: Neurotransmission
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...